 Connection
Cynthia Epperson to Premenstrual Dysphoric Disorder
This is a "connection" page, showing publications Cynthia Epperson has written about Premenstrual Dysphoric Disorder.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
3.470 |
|
|
|
-
Hantsoo L, Grillon C, Sammel M, Johnson R, Marks J, Epperson CN. Response to sertraline is associated with reduction in anxiety-potentiated startle in premenstrual dysphoric disorder. Psychopharmacology (Berl). 2021 Oct; 238(10):2985-2997.
Score: 0.718
-
Epperson CN, Hantsoo LV. Making Strides to Simplify Diagnosis of Premenstrual Dysphoric Disorder. Am J Psychiatry. 2017 01 01; 174(1):6-7.
Score: 0.523
-
Hantsoo L, Epperson CN. Premenstrual Dysphoric Disorder: Epidemiology and Treatment. Curr Psychiatry Rep. 2015 Nov; 17(11):87.
Score: 0.483
-
Barone JC, Ho A, Osborne LM, Eisenlohr-Moul TA, Morrow AL, Payne JL, Epperson CN, Hantsoo L. Luteal phase sertraline treatment of premenstrual dysphoric disorder (PMDD): Effects on markers of hypothalamic pituitary adrenal (HPA) axis activation and inflammation. Psychoneuroendocrinology. 2024 Nov; 169:107145.
Score: 0.221
-
Miller KN, Standeven L, Morrow AL, Payne JL, Epperson CN, Hantsoo L. GABAergic neuroactive steroid response to sertraline in premenstrual dysphoric disorder. Psychoneuroendocrinology. 2024 Feb; 160:106684.
Score: 0.211
-
Dubol M, Wikström J, Lanzenberger R, Epperson CN, Sundström-Poromaa I, Comasco E. Grey matter correlates of affective and somatic symptoms of premenstrual dysphoric disorder. Sci Rep. 2022 04 09; 12(1):5996.
Score: 0.189
-
Gu X, Dubol M, Stiernman L, Wikström J, Hahn A, Lanzenberger R, Epperson CN, Bixo M, Sundström-Poromaa I, Comasco E. White matter microstructure and volume correlates of premenstrual dysphoric disorder. J Psychiatry Neurosci. 2022 Jan-Feb; 47(1):E67-E76.
Score: 0.187
-
Wikman A, Sacher J, Bixo M, Hirschberg AL, Kopp Kallner H, Epperson CN, Comasco E, Sundström Poromaa I. Prevalence and correlates of current suicidal ideation in women with premenstrual dysphoric disorder. BMC Womens Health. 2022 02 11; 22(1):35.
Score: 0.187
-
Bäckström T, Ekberg K, Hirschberg AL, Bixo M, Epperson CN, Briggs P, Panay N, O'Brien S. A randomized, double-blind study on efficacy and safety of sepranolone in premenstrual dysphoric disorder. Psychoneuroendocrinology. 2021 11; 133:105426.
Score: 0.182
-
Comasco E, Kopp Kallner H, Bixo M, Hirschberg AL, Nyback S, de Grauw H, Epperson CN, Sundström-Poromaa I. Ulipristal Acetate for Treatment of Premenstrual Dysphoric Disorder: A Proof-of-Concept Randomized Controlled Trial. Am J Psychiatry. 2021 03 01; 178(3):256-265.
Score: 0.172
-
Dubol M, Epperson CN, Lanzenberger R, Sundström-Poromaa I, Comasco E. Neuroimaging premenstrual dysphoric disorder: A systematic and critical review. Front Neuroendocrinol. 2020 04; 57:100838.
Score: 0.164
-
Ismaili E, Walsh S, O'Brien PMS, Bäckström T, Brown C, Dennerstein L, Eriksson E, Freeman EW, Ismail KMK, Panay N, Pearlstein T, Rapkin A, Steiner M, Studd J, Sundström-Paromma I, Endicott J, Epperson CN, Halbreich U, Reid R, Rubinow D, Schmidt P, Yonkers K. Fourth consensus of the International Society for Premenstrual Disorders (ISPMD): auditable standards for diagnosis and management of premenstrual disorder. Arch Womens Ment Health. 2016 12; 19(6):953-958.
Score: 0.126
-
Comasco E, Hahn A, Ganger S, Gingnell M, Bannbers E, Oreland L, Wikström J, Epperson CN, Lanzenberger R, Sundström-Poromaa I. Emotional fronto-cingulate cortex activation and brain derived neurotrophic factor polymorphism in premenstrual dysphoric disorder. Hum Brain Mapp. 2014 Sep; 35(9):4450-8.
Score: 0.107
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|